KENNEY CHRISTOPHER JOHN (CIK 1880129) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-31). Recent activity: Sell XENE (6,368 shares), Sell XENE (700 shares), Buy XENE (3,750 shares), Sell XENE (1,410 shares), Buy XENE (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Sell | 6,368 | $383,145 |
| 2026-08-31 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Sell | 700 | $42,684 |
| 2026-03-13 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Buy | 3,750 | $0 |
| 2026-03-13 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Sell | 1,410 | $77,874 |
| 2026-03-11 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Buy | 7,500 | $0 |
| 2026-03-11 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Sell | 2,771 | $166,565 |
来源：SEC Form 4 申报文件 · 截至 2026-08-31